Skip to main content

Intuity Medical gets new CEO, George Zamanakos, months after ditching IPO plans

The glucose blood test maker pulled the plug in June on plans for an initial public offering in which it had hoped to raise about $75 million.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.